Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD) by Nadarajah, V.D, van Putten, M, Chaouch, A, Garrood, P, Straub, V, Lochmüller, H, Ginjaar, H.B, Aartsma-Rus, A.M, van Ommen, G.J.B, den Dunnen, J.T, t Hoen, P.A.C

Get full text

Relative power and sample size analysis on gene expression profiling data by Iterson, M. van, Hoen, P.A.C. 't, Pedotti, P, Hooiveld, G.J.E.J, Dunnen, J.T. den, Ommen, G.J.B. van, Boer, J.M, Menezes, R.X

Get full text

T.P.21 Exon skipping for dysferlinopathies by Aartsma-Rus, A, Verwey, N, Schneiderat, P, van der Maarel, S.M, van Ommen, G.J.B, Houweling-Gazzoli, I

Get full text

T.P.26 Low dystrophin levels increase survival and improve pathology and motor function in dystrophin/utrophin double knockout mice by van Putten, M, Hulsker, M, Young, C, Nadarajah, V.D, Heemskerk, H, t Hoen, P.A.C, van Ommen, G.J.B, Aartsma-Rus, A.M

Get full text

P4.29 Differential tissue expression and decay of dystrophin mRNA and protein by Spitali, P, van Putten, M, Vossen, R.H, den Dunnen, J.T, van Ommen, G.J.B, t Hoen, P.A.C, Aartsma-Rus, A

Get full text

O.11 Development of systemic antisense treatment in dystrophic mouse models for Duchenne muscular dystrophy by Aartsma-Rus, A.M, Tanganyika-de Winter, C.L, van Putten, M, Karnaoek, T, van Deutekom, J.C.T, van Ommen, G.J.B

Get full text

O.13 Interference of myostatin and TGF-beta signaling by antisense-mediated exon skipping in ALK4/5 receptors by Kemaladewi, D.U, van Heiningen, S.H, Aartsma-Rus, A, van Ommen, G.J.B, ten Dijke, P, t Hoen, P.A.C, Hoogaars, W.M.H

Get full text

P1.22 Low dystrophin levels improve life expectancy, phenotype and functional performance in the mdx/utrn -/- mouse by van Putten, M, Hulsker, M.A, van Heiningen, S.H, Nadarajah, V.D, Hoen, P.A.C. ’t, van Ommen, G.J.B, Aartsma-Rus, A.M

Get full text

P1.48 Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring Duchenne muscular dystrophy (DMD) disease progression by t Hoen, P.A.C, Nadarajah, V.D, van Putten, M, Chaouch, A, Garrood, P, Straub, V, Ginjaar, H.B, Aartsma-Rus, A.M, van Ommen, G.J.B, Dunnen, J.T. den, Lochmüller, H

Get full text

T.P.5.04 Effect of a mild exercise regime on disease parameters in the mdx mouse model by van Putten, M, de Winter, C.L, van Roon-Mom, W.M.C, van Ommen, G.J.B, tHoen, P.A.C, Aartsma-Rus, A.M

Get full text

G.P.8.01 Functional muscle, histological and biomarker analysis in the mdx mouse by van Putten, M, de Winter, C.L, van Deutekom, J.C.T, van Ommen, G.J.B, Aartsma-Rus, A

Get full text

T.P.2.04 Optimization of antisense-mediated exon skipping in mouse models for Duchenne muscular dystrophy by Aartsma-Rus, A, Heemskerk, H.A, de Winter, C.L, van Putten, M, De Kimpe, S, van Deutekom, J.C.T, van Ommen, G.J.B

Get full text

T.P.1.04 Dual exon skipping in myostatin and dystrophin as a potential therapy for Duchenne muscular dystrophy by Kemaladewi, D.U, Hoogaars, W.M.H, van Heiningen, S.H, van Deutekom, J.C.T, den Dunnen, J.T, van Ommen, G.J.B, Aartsma-Rus, A.R, ten Dijke, P, t Hoen, P.A.C

Get full text

Deleterious alleles in the human genome are on average younger than neutral alleles of the same frequency by Kiezun, Adam, Pulit, Sara L, Francioli, Laurent C, van Dijk, Freerk, Swertz, Morris, Boomsma, Dorret I, van Duijn, Cornelia M, Slagboom, P Eline, van Ommen, G J B, Wijmenga, Cisca, de Bakker, Paul I W, Sunyaev, Shamil R

Get full text

T.P.2.05 Direct comparison of 2′ O -methyl and PMO AONs for exon skipping in preclinical model in DMD by Heemskerk, H.A, de Winter, C.L, de Kimpe, S.J, van Kuik-Romeijn, P, Heuvelmans, N, Platenburg, G.J, van Ommen, G.J.B, van Deutekom, J.C.T, Aartsma-Rus, A

Get full text

G.P.12.01 Epidemiology of the dystrophinopathies in the Netherlands by van den Bergen, J.C, Straathof, C.S.M, Pangalila, R.F, Broekgaarden, R, Overweg-Plandsoen, W.C.G, Aartsma-Rus, A.M, Ginjaar, H.B, Bakker, E, van Ommen, G.J.B, Verschuuren, J.J.G

Get full text

Genome-wide expression profiling identifies a deregulated cellular network associated with human papillomavirus infection by Boer, J.M., Karim, R., Meyers, C., van Ommen, G.J.B., Melief, C.J.M., van der Burg, S.H.

Get full text

Tissue-specific transcript annotation and expression profiling with complimentary next-generation sequencing technologies by Hestand, M.S., Klingenhoff, A., Harbers, M., van Ommen, G.J.B., Dunnen, J.T. Den, ‘t Hoen, P.A.C.

Get full text

High-resolution in situ hybridization using DNA halo preparations by Wiegant, J., Kalle, W., Mullenders, L., Brookes, S., Hoovers, J.M.N., Dauwerse, J.G., van Ommen, G.J.B., Raap, A.K.

Get full text

T.P.1 03 Gene expression profiling to monitor therapeutic and adverse effects of antisense-induced exon skipping for Duchenne muscular dystrophy by ’t Hoen, P.A.C., van der Wees, C.G.C., Aartsma-Rus, A., Turk, R., Goyenvalle, A., Danos, O., Garcia, L., van Ommen, G.J.B., van Deutekom, J.C.T., den Dunnen, J.T.

Get full text